Text Size: A+ A- A  •   Text Only Site
Topics
  A-Z
Data &
 Statistics
Forms &
Publications
News &
Advisories
Licensing &
Certification
Rules &
Regulations
Public Health
Directory
Print this Article   Bookmark and Share
Tuberculosis Control 

TB Webinar

Webinar Title: Anti TNF and Other Immunosuppresive Therapies: Screening and Preventing TB.  Presented by Kevin L. Winthrop, MD, MPH Oregon TB Control Medical Consultant and Assistant Professor of Infectious Diseases Oregon Health & Science University.


  
 

Preventing and controlling the spread of TB in Oregon

Tuberculosis (TB) is a bacterial disease primarily of the lungs. It is airborne and spreads when someone with active TB disease coughs, laughs or sings.

To control the spread of TB in Oregon, the TB Control Program works with local health departments and private medical providers to: 1) identify and treat TB disease; 2) identify, evaluate, and treat newly infected contacts to infectious TB cases; 3) screen high-risk populations for TB infection. The TB Program provides lab testing, technical assistance, TB medications and analysis of surveillance data to assist with accomplishing these goals.

New LTBI Treatment Regimen

On December 9, 2011, the CDC released recommendations on the use of a new 12 dose regimen consisting of isoniazid and rifapentine to treat latent TB infection. This represents a major advancement in preventing future cases of TB disease.

These recommendations can be found here:

http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6048a3.htm?s_cid=mm6048a3_e&source=govdelivery

A summary of all the current treatment options for LTBI can be found here:                               

http://www.cdc.gov/tb/publications/factsheets/treatment/LTBItreatmentoptions.htm

Resources

Forms

TB Control Program Surveys

Guidelines

Web Editor Access